The MICRO Crusher Experts : Benefits of Senya Crusher s Technology prleap.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prleap.com Daily Mail and Mail on Sunday newspapers.
The intersection of edge computing and cloud is creating new ways to leverage distributed and centralized computing. iStock
The age-old saying that “beauty is in the eye of the beholder” may help explain why virtually everyone has their own view on what we can expect from computing at the edge. For some it’s the realization of autonomous vehicles; for others it may be industrial automation or more effective monitoring of patient health. The reality is that edge is a concept that is subjective to an individual’s experience and vision, with applications and use cases still taking shape and many more not yet on the drawing board.
Deeplite raises $6M seed to deploy ML on edge with fewer compute resources
One of the issues with deploying a machine learning application is that it tends to be expensive and highly compute intensive. Deeplite, a startup based in Montreal, wants to change that by providing a way to reduce the overall size of the model, allowing it to run on hardware with far fewer resources.
Today, the company announced a $6 million seed investment. Boston-based venture capital firm PJC led the round with help from Innospark Ventures, Differential Ventures and Smart Global Holdings. Somel Investments, BDC Capital and Desjardins Capital also participated.
Wix vs WordPress? Mueller Says Solve Content Issues searchenginejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from searchenginejournal.com Daily Mail and Mail on Sunday newspapers.
Home / Top News / Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer Gene therapy development expert Petra Kaufmann, M.D.,
joins as chief medical officer –
WALTHAM, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and non-rare diseases, today announced the completion of its leadership team. Collectively, the executives represent a diverse team of proven leaders in gene therapy who have successfully developed novel platforms and translated the